Literature DB >> 8192465

In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.

A A van Zwet1, J C Thijs, W Schievink-de Vries, J Schiphuis, J A Snijder.   

Abstract

Seventy isolates of Helicobacter pylori from antral biopsy samples were tested for their susceptibilities to metronidazole by agar dilution. Seven (10%) of these clinical isolates appeared to be resistant to metronidazole. Sixty-three strains were susceptible. In 42 (67%) of the 63 susceptible isolates, resistant isolates were obtained by serial passage on plates containing subinhibitory concentrations of metronidazole. In 10 of these 42 strains, the acquired resistance appeared to be unstable. The difference between the stability of resistance that occurred after one or two passages and the stability of resistance that occurred after three passages was statistically significant (P < 0.006). Primary resistance in clinical isolates was a stable phenomenon. Whether the resistance that emerges during therapy in patients is stable or unstable needs to be established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192465      PMCID: PMC284456          DOI: 10.1128/AAC.38.2.360

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

2.  Metronidazole-resistant Helicobacter pylori.

Authors:  M C Becx; A J Janssen; H A Clasener; R W de Koning
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

3.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

4.  Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

Authors:  T D Gootz; D B Jackson; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

Authors:  J C Thijs; A A Van Zwet; H B Oey
Journal:  Scand J Gastroenterol       Date:  1993-11       Impact factor: 2.423

7.  Resistance to cefamandole: a collaborative study of emerging clinical problems.

Authors:  C C Sanders; R C Moellering; R R Martin; R L Perkins; D G Strike; T D Gootz; W E Sanders
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

8.  Cure of duodenal ulcer after eradication of Helicobacter pylori.

Authors:  L L George; T J Borody; P Andrews; M Devine; D Moore-Jones; M Walton; S Brandl
Journal:  Med J Aust       Date:  1990-08-06       Impact factor: 7.738

9.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

10.  Characterization of beta-lactamase induction in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  10 in total

1.  Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

Authors:  A A van Zwet; J C Thijs; B de Graaf
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.

Authors:  J F Weel; R W van der Hulst; Y Gerrits; G N Tytgat; A van der Ende; J Dankert
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.

Authors:  G Wang; T J Wilson; Q Jiang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.

Authors:  A A van Zwet; W A de Boer; P M Schneeberger; J Weel; A R Jansz; J C Thijs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

7.  Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.

Authors:  S Matsumoto; Y Washizuka; Y Matsumoto; S Tawara; F Ikeda; Y Yokota; M Karita
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

8.  Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Authors:  M J Buckley; H X Xia; D M Hyde; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

9.  Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.

Authors:  N S Taylor; J G Fox; N S Akopyants; D E Berg; N Thompson; B Shames; L Yan; E Fontham; F Janney; F M Hunter
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice.

Authors:  P J Jenks; A Labigne; R L Ferrero
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.